MF101
MF101 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
Sleep Quality in CHIMES (MF101)
Clinical Trials (4)
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
Sleep Quality in CHIMES (MF101)
All 4 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 4